The DOI matches its Crossref record; 99 of the 104 references it cites were found in a registry or an index.
Epigenetic gene silencing in cancer: the DNA hypermethylome
Open accessAbstract
Epigenetic gene inactivation in transformed cells involves many 'belts of silencing'. One of the best-known lesions of the malignant cell is the transcriptional repression of tumor-suppressor genes by promoter CpG island hypermethylation. We are in the process of completing the molecular dissection of the entire epigenetic machinery involved in methylation-associated silencing, such as DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylases, histone methyltransferases, histone demethylases and Polycomb proteins. The first indications are also starting to emerge about how the combination of cellular selection and targeted pathways leads to abnormal DNA methylation. One thing is certain already, promoter CpG island hypermethylation of tumor-suppressor genes is a common hallmark of all human cancers. It affects all cellular pathways with a tumor-type specific profile, and in addition to classical tumor-suppressor and DNA repair genes, it includes genes involved in premature aging and microRNAs with growth inhibitory functions. The importance of hypermethylation events is already in evidence at the bedside of cancer patients in the form of cancer detection markers and chemotherapy predictors, and in the approval of epigenetic drugs for the treatment of hematological malignancies. In the very near future, the synergy of candidate gene approaches and large-scale epigenomic technologies, such as methyl-DIP, will yield the complete DNA hypermethylome of cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the epigenetic landscape of human malignancies exhibits massive reprogramming in their DNA methylation patterns.”
From Meta-hallmarks of aging and cancer (2023) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationmiR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Cited by
Items 501–600 of 725
Épigénétique et cancer: La méthylation dans tous ses états
Gorse, M., Bianchi, C., & Proudhon, C. (2024) · médecine/sciences · doi:10.1051/medsci/2024180 · Cited by 5
Epigenetic Modification of MicroRNAs
Pal, D., Ghatak, S., & Sen, C. K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405544-5.00003-4 · Cited by 9
Jazii, R. (2011) · Journal of sciences, Islamic Republic of Iran · doi:10.22059/jsciences.2011.23584 · Cited by 5
Molecular Basis of Lung Carcinogenesis
Fong, K. M., Larsen, J. E., Wright, C. M., Sriram, K. B., Davidson, M. R., Daniels, M. G., Sekido, Y., Bowman, R., Yang, I. A., & Minna, J. D. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_28 · Cited by 6
Pereira, K. M. A., Costa, S. F. D. S., Pereira, N. B., Diniz, M. G., Castro, W. H., Gomes, C. C., & Gomez, R. S. (2017) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2017.07.010 · Cited by 5
“These abnormalities include promoter CpG island DNA hypermethylation, which is related to transcriptional silencing of genes, such as tumor suppressor genes.(30,36) DNA hypomethylation has also been found in many types of cancers, but its biologic significance is not understood.”
BackgroundMizuguchi, M., Hara, T., Yoshita‐Takahashi, M., Kohda, T., Tanaka, Y., & Nakamura, M. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100984 · Cited by 5
“DNA methylation of gene promoters in tumor cells has been shown to mostly down-regulate their transcription, as DNA methylation prevents the accession of transcriptional factors to promoter regions [11].”
BackgroundInfluentialRole of the WOR1 Promoter of Candida albicans in Opaque Commitment
Conway, T. P., Conway, K., Boksa, F. A., Pujol, C., Wessels, D. J., & Soll, D. R. (2021) · mBio · doi:10.1128/mbio.02320-21 · Cited by 5
Translational epigenetics in neurodegenerative diseases
Tabassum, H., & Parvez, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85652-2.00020-8 · Cited by 6
Tirado, C. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.06601-6 · Cited by 4
Yao, Y., Liu, K., Wu, Y., Zhou, J., Jin, H., Zhang, Y., & Zhu, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.962412 · Cited by 7
“These data suggest that methylation changes may lead to abnormal gene expression, confirming that alterations in DNA methylation can be exploited in cancer diagnosis (Esteller, 2007).”
BackgroundCancer Genetics: A Primer for Surgeons
Benson, J. R., & Liau, S. (2008) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.04.011 · Cited by 5
“The BRCA-1 and APC genes can be inactivated by hypermethylation and in the case of the former this can act as a second hit in hereditary forms of breast cancer [ 61 ].”
BackgroundFree radical-mediated cytosine C-5 methylation triggers epigenetic changes during carcinogenesis
Kasai, H., Kawai, K., & Li, Y. (2013) · BioMolecular Concepts · doi:10.1515/bmc-2012-0052 · Cited by 5
“Natural selection, instead of molecular targeting, is also involved in the formation of gene- and tissue-specific methylation patterns in cancer cells (62) .”
BackgroundRegulation of Hematopoietic Stem Cells
Rörby, E. (2014) · Lund University Publications (Lund University) · Cited by 6
Targeting the microbiota‐ miRNA ‐protease axis: A new therapeutic avenue in melanoma
Katsoulieris, E. N., Ioannou, P., & Afratis, N. A. (2026) · FEBS Journal · doi:10.1111/febs.70386 · Cited by 4
“Conversely, miRNA expression in each context depends on epigenetic factors that influence the expression of enzymes involved in miRNA biogenesis [17], as well as on the expression and activity of TFs involved in its synthesis [18].”
Chen, L., Xiang, L., Sun, W.-J., Zhai, Y., Gao, S., Fan, Y., & Wang, K. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.252.297 · Cited by 4
Guan, H., Lu, J., Qu, M., Meng, L., Guo, Y., Li, X., & Shen, H. (2021) · Neoplasma · doi:10.4149/neo_2020_200928n1035 · Cited by 4
“54 The occurrence of cancer is associated with changes in genomic levels, as well as epigenetic 55 changes such as DNA methylation play important roles in cancer [7-9].”
BackgroundHuman Endogenous Retroviruses in Diseases
Fan, T.-J., & Cui, J. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-40086-5_15 · Cited by 5
Conway, K., Edmiston, S. N., Vondras, A. M., Reiner, A., Corcoran, D. L., Shen, R., Parrish, E., Hao, H., Lin, L., Kenney, J. M., et al. (2024) · JCO Precision Oncology · doi:10.1200/po-24-00375 · Cited by 5
Gasdermin E as a potential target and biomarker for CRISPR-Cas9-based cancer therapy
Tarin, M., & Saljooghi, A. S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116961 · Cited by 4
Direct genetic transformation bypasses tumor-associated DNA methylation alterations
Hetzel, S., Hodis, E., Triglia, E. T., Kovacsovics, A., Steinmann, K. E., Gnirke, A., Cui, M., McQuaid, D. C., Weigert, R., Pohl, G., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03650-2 · Cited by 3
Emerging Concepts in Neuro-Oncology
Sciuscio, D., & Hegi, M. E. (2012) · Springer eBooks · doi:10.1007/978-0-85729-458-6 · Cited by 5
Cancer Biology and the Principles of Targeted Cancer Drug Discovery
Hillmann, P., Schmitz, D., Mestan, J., D'Allonzo, S., & Fabbro, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12390-x · Cited by 5
Epigenetic sampling effects: nephrectomy modifies the clear cell renal cell cancer methylome
Neste, C. V., Laird, A., O’Mahony, F. C., Criekinge, W. V., Deforce, D. L. D., Nieuwerburgh, F. V., Powles, T. B., Harrison, D. J., Stewart, G. D., & Meyer, T. D. (2017) · Cellular Oncology · doi:10.1007/s13402-016-0313-5 · Cited by 4
Wilczyński, J. R., Wilczyński, M., & Paradowska, E. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1201497 · Cited by 5
Beekman, R., Kulis, M., & Martín-Subero, J. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800140-0.00009-1 · Cited by 4
Identification of HCC-Related Genes Based on Differential Partial Correlation Network
Gao, Y., Chang, X., Xia, J., Sun, S., Mu, Z., & Liu, X. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.672117 · Cited by 4
“For example, promoter hypermethylation can lead to the silencing of genes functioning in some cancer-related pathways, such as DNA repair and cell cycle regulation (Esteller, 2007).”
BackgroundXu, F., Sun, W., Li, P., Chen, J., Zhu, D., Sun, X., Wang, J., Feng, J., Song, K., & Duan, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120072 · Cited by 4
“Since DNAmethylation of the gene promoter was known to be associated with the regulation of tissue- and cell type-specific gene expression [30,31], we speculated that the methylation of the CpG island was responsible for the difference in expression of Sept4 in different cells and tissues.”
BackgroundEpigenetic Modifications: Therapeutic Potential in Cancer
Sachan, M., & Kaur, M. (2015) · Brazilian Archives of Biology and Technology · doi:10.1590/s1516-8913201500132 · Cited by 6
“Later studies have shown that the most recognized epigenetic disruption in human tumors is the CpG island promoter hypermethylation– associated silencing of tumor suppressor genes, such as genes involved in DNA repair (BRCA1, MGMT and MLH1), signal transduction (RASSF1A), cell cycle regulation (p16INK4a), apoptosis (D…”
BackgroundThe Epigenetic Targets of Berry Anthocyanins in Cancer Prevention
El-Ella, D. M. A., & Bishayee, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812494-9.00006-8 · Cited by 5
Chemical Carcinogenesis and Epigenetics
Darwanto, A., Ornam, J. D. V., Lao, V. V., & Sowers, L. C. (2010) · Humana Press eBooks · doi:10.1007/978-1-61737-995-6_12 · Cited by 4
Cancer Stem Cells: An Ever-Hiding Foe
Wilczyński, J. R. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_8 · Cited by 4
Gormley, M., Lawrence, W. R., Plascak, J. J., Paskett, E. D., Omene, C. O., & Llanos, A. A. M. (2025) · npj Breast Cancer · doi:10.1038/s41523-025-00812-0 · Cited by 4
Keshet, G., Barbaric, I., & Benvenisty, N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115743 · Cited by 4
Alemany-Cosme, E., Cruz-Chamorro, D. A., Hervás, D., Garcia, D., Martínez-Tomás, R., Briones-Gómez, A., Galbis, J. M., Calvo, A., Juan, Ó., Lahoz, A., et al. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-02026-4 · Cited by 5
“In cancer tissues, DNA methylation changes typically include focal hypermeth-ylation—particularly in promoter regions of tumor suppressor genes—and widespread hypomethylation across intergenic and repetitive regions [30, 31].”
Meenakshi, S., Maharana, K. C., Nama, L., Vadla, U. K., Dhingra, S., Ravichandiran, V., Murti, K., & Kumar, N. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230809110444 · Cited by 3
“However, hypermethylation of CpG islands initially recruits methyl-CpG binding domain (MBD) proteins, which further promotes the recruitment of histone-modifying and chromatin-remodelling complexes to the methylated promoter region, which in turn, silences the target gene [17, 18].”
Progress in genome-inspired treatment decisions for multifocal lung adenocarcinoma
Powell, C., Saddoughi, S. A., & Wigle, D. A. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2286277 · Cited by 3
Association of dietary inflammatory index with gynecological cancers in NHANES 2011–2018
Chen, C., Zheng, M., Dong, X., Zhang, P., Bao, Z., Cao, Y., Liu, Y., Yan, J., Guo, Y., & Zeng, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1560987 · Cited by 3
Cha, H. J., Lee, D. B., Jung, H. N., Choi, Y., & Suh, H. S. (2014) · Clinical and Experimental Dermatology · doi:10.1111/ced.12548 · Cited by 3
Epigenetic Nutraceuticals in Cancer Treatment
Šupić, G., Zeljić, K., & Magić, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811517-6.00015-5 · Cited by 3
Naderi, A. (2020) · Chromosome Research · doi:10.1007/s10577-020-09638-x · Cited by 3
“Of note, it is established that DNA hypermethylation is a common mechanism for epigenetic silencing of gene expression in cancer (Baylin 2005; Esteller 2007).”
BackgroundE-Cadherin, NFATC3 , and PLP2 Are Differentially Methylated in Multiple Cancers
Lotesto, M. J., Wallace, C. J., & Raimondi, S. L. (2020) · Epigenetics Insights · doi:10.1177/2516865720964802 · Cited by 3
LATS in cancer repression: Extracting its role in hippo pathway and beyond
Akhtar, S. (2023) · Gene Reports · doi:10.1016/j.genrep.2023.101826 · Cited by 7
The differential expression patterns of Atg9a and Atg9b in cells of the reproductive organs
Lee, M., Son, S., Lim, H. J., & Song, H. (2024) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2023.06737 · Cited by 3
Upstream regulation of microRNA-9 through a complex cellular machinery during neurogenesis
Kuriakose, D., Zhu, H., Zhao, Y., Iraqi, F. A., Morahan, G., & Xiao, Z. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149328 · Cited by 2
“…in neural progenitor cells and mouse brain) suggest that this modification can derepress genes silenced by methylation, potentially explaining increased miR-9 expression through Tet-mediated conversion of 5mC to 5hmC (Pan, et al., 2016; Spruijt, et al., 2013; Esteller, 2007; Yu, et al., 1708).”
Methylation of the promoter region of the MTRR gene in childhood acute lymphoblastic leukemia
Bai, J. Y., Li, L., Li, Y., Chen, Q., Zhang, L., & Xie, X. (2019) · Oncology Reports · doi:10.3892/or.2019.7114 · Cited by 2
Molecular Strategies Against Sulfur Mustard Toxicity
Korkmaz, A., Yaren, H., Kunak, Z. I., Uysal, B., Topal, T., Sadır, S., & Öter, Ş. (2010) · Cited by 3
Steinritz, D., & Thiermann, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-17900-1_149 · Cited by 4
Kaliszewska, A., & Jager, P. L. D. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.12.012 · Cited by 3
Une expression dérégulée dans les cancers : des causes potentielles multiples
Dupasquier, S., & Prévostel, C. (2008) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2008.10.003 · Cited by 5
DNA methylation of stem cell surface markers in colon cancers
Yi, J. M. (2012) · Genes & Genomics · doi:10.1007/s13258-012-0038-4 · Cited by 3
“kr CpG island hypermethylation at the promoters of tumor- suppressor genes is a hallmark of all human cancers (Esteller, 2007).”
BackgroundPark, C. W., Zeng, Y., & Steer, C. J. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9167-9 · Cited by 3
“CpG methylation is critical to a variety of genetic regulatory mechanisms such as genomic imprinting [4], X-chromosome inactivation in female [8], and inactivation of tumor suppressor genes during carcinogenesis [ 5 ].”
BackgroundEpigenetic Analysis in the Search for Tumor Suppressor Genes
Han, Z. (2010) · Epigenomics · doi:10.2217/epi.10.29 · Cited by 3
Downregulation of SM22α protein by hypermethylation of its promoter in colorectal cancer
Liu, Y., Wei, E., Zhao, J., Kong, D., & Li, B. (2018) · Oncology Letters · doi:10.3892/ol.2018.8350 · Cited by 3
“Hypermethylation in gene promoter regions may lead to transcriptional silencing (7).”
Francipane, M. G., & Lagasse, E. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7876-8_14 · Cited by 3
“Polycomb group (PcG) proteins have been suggested to serve as recruitment platforms for DNMTs [ 108 , 109 ], helping maintain the transcriptional repression of target genes through many cycles of cell division.”
BackgroundKarlic, H., & Varga, F. (2009) · Epigenetics and human health · doi:10.1002/9783527628384.ch15 · Cited by 3
Saumet, A., Vetter, G., Cougot, N., Bouttier, M., Rage, F., Arar, K., & Lecellier, C. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8533-8_22 · Cited by 4
Cheng, N., Skead, K., Singhawansa, A., Ouellette, T. W., Elliott, M. J., Cescon, D. W., Bratman, S. V., Carvalho, D. D. D., Soave, D. M., & Awadalla, P. (2023) · medRxiv · doi:10.1101/2023.01.30.23285027 · Cited by 5
Epigenomic profiling of active regulatory elements by enrichment of unmodified CpG dinucleotidesPreprint
Tosti, L., Mould, C., Gatehouse, I., Camargo, A. V., Smith, A., Ubych, K., Laird, P. W., Kennefick, J., & Neely, R. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.16.575381 · Cited by 3
Zhao, X., & Qiu, L. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114849 · Cited by 2
Update of the Methyltransferase Gene Family: Classification, Evolution and Biological Functions
Katsafadou, A. I., Falnes, P. Ø., Bruford, E. A., Braschi, B., Hanson, Q., Hall, M. D., Thompson, D. C., Nebert, D. W., & Vasiliou, V. (2026) · Human Genomics · doi:10.1186/s40246-026-00949-4 · Cited by 3
“This gene silencing facilitates unchecked cellular proliferation and impairs apoptosis mechanisms [20].”
Interaction of flavonoids with DNA: implications in cancer treatment
Raskar, D. A., Uday, D., & Khattar, E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11809-8 · Cited by 3
Context-dependent synthetic lethality — an emerging precision therapeutic approach
Chang, L., Shaw, K. L., Vázquez, F., & Sellers, W. R. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00929-9 · Cited by 8
“In cancer, these changes can inactivate tumour suppressor genes or other essential regulatory genes, contributing to oncogenesis and tumour progression 121 .”
Novel Molecular Strategies Against Sulfur Mustard Toxicity
Kunak, Z. I., Toygar, M. T., & Poyrazoǧlu, Y. (2012) · TAF Preventive Medicine Bulletin · doi:10.5455/pmb.1-1328011599 · Cited by 2
Morvan, D., & Cachin, F. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00778 · Cited by 2
“3,4 DNA methylation has received extensive attention for more than a decade, along with histone methylation.”
Current Strategies in Breast Cancer Therapy: Role of Epigenetics and Nanomedicine
Sengupta, P., Choudhury, H., Dutta, S., Jacob, S., Kesharwani, P., & Gorain, B. (2022) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202100276 · Cited by 2
Novel Insights on the Role of Epigenetics in Androgen Receptor’s Expression in Prostate Cancer
Camilo, V., Pacheco, M. B., Moreira‐Silva, F., Outeiro-Pinho, G., Gaspar, V. M., Mano, J. F., Marques, C. J., Henrique, R., & Jerónimo, C. (2023) · Biomolecules · doi:10.3390/biom13101526 · Cited by 2
“One possible contributor is aberrant DNA methylation, which has been shown to contribute to cancer development and progression [7–9].”
BackgroundWang, X., Gao, Y., Miao, R., Li, L., Nanding, A., Liu, Y., & Zhang, X. (2023) · PubMed Central · Cited by 2
Epigenetics and cancer stem cells—The world of cancer genesis: A review
Tiwari, N., Mishra, J., Singh, N., Mishra, S. K., Trisal, M., & Verma, S. (2025) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_388_24 · Cited by 2
Human Health and Ecological Risk Analysis
Bleam, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804178-9.00010-0 · Cited by 2
Epigenetics of Colorectal Cancer
Carmona, F. J., & Esteller, M. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8_4 · Cited by 2
“lated tumour types – whereas breast cancer matches for p16INK4A but also shows BRCA1 and DAPK hypermethylation (Esteller, 2007b; Esteller et al., 2001).”
BackgroundMolecular Pathology of Gastrointestinal Cancer
Yantiss, R. K., & Samowitz, W. S. (2012) · Surgical pathology clinics · doi:10.1016/j.path.2012.08.002 · Cited by 3
Kawai, K., Li, Y., Song, M.-F., Ootsuyama, Y., Kakehashi, A., Wanibuchi, H., Ootsuyama, A., Norimura, T., & Kasai, H. (2012) · Genes and Environment · doi:10.3123/jemsge.34.123 · Cited by 2
methGraph: A genome visualization tool for PCR-based methylation assays
Lefever, S., Hoebeeck, J., Pattyn, F., Tusnády, G., Paepe, A. D., Speleman, F., Arányi, T., & Vandesompele, J. (2010) · Epigenetics · doi:10.4161/epi.5.2.11161 · Cited by 2
Pancreatic Ductal Adenocarcinoma: Implications of Epigenetic Role Related the Src Pathway
Me, P. I. (2013) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000247 · Cited by 2
“DNA methylation of CpG islands located in the promoter regions of tumor-related genes, such as p14, p15, p16, p73, APC, hMLH1, BRCA1, MGMT, GSTP1, CDH1, TIMP3 and DAPK-1, is associated with silencing of such genes [1].”
BackgroundIntegrated Genomic Analysis of Breast Cancers
Chaffanet, M., Addou-Klouche, L., Adélaïde, J., Cornen, S., Bekhouche, I., Finetti, P., Guillé, A., Sircoulomb, F., Raynaud, S., Bertucci, F., et al. (2012) · Balkan Journal of Medical Genetics · doi:10.2478/v10034-012-0023-x · Cited by 2
“CpG methylation-dependent silencing is now considered as an important mechanism of TSG inactivation in cancer cells, in addition to somatic genetic lesions [41].”
BackgroundMensink, H. W., Paridaens, D. A., & de Klein, A. (2009) · Expert Review of Ophthalmology · doi:10.1586/eop.09.53 · Cited by 2
Multivariate Boosting for Integrative Analysis of High-Dimensional Cancer Genomic Data
Xiong, L., Kuan, P. F., Tian, J., Keleş, S., & Wang, S. (2014) · Cancer Informatics · doi:10.4137/cin.s16353 · Cited by 2
Epigenetic Alterations in Pancreatic Cancer
Ayars, M., & Goggins, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6549-2_9 · Cited by 2
Epigenetic Reprogramming Induced Pluripotency
Meiliana, A., & Wijaya, A. (2011) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v3i2.139 · Cited by 2
Brettingham‐Moore, K. H., & Taberlay, P. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00002-3 · Cited by 4
Malignant Transformation and Epigenetics
Han, Y., Ren, J., Yu, W., Terashima, M., & Muegge, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800957-4.00007-2 · Cited by 2
Bánáti, F., Koroknai, A., Szenthe, K., Tereh, T., Hidasi, A., Bánkuti, B., Buzás, K., Lemnitzer, F., Ruzsics, Z., Szathmáry, S., et al. (2017) · Journal of Microbial & Biochemical Technology · doi:10.4172/1948-5948.1000349 · Cited by 2
“Moreover, tumor specific hypermethylated DNA sequences (the hypermethylome) appearing in biological fluids may also be exploited for early detection and staging of malignant tumors or may predict the prognosis of the patients [56-58].”
BackgroundSen, S., & Maulik, U. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/ely021 · Cited by 2
Elbordiny, M., Alghandour, A. H., Elwafa, R. A., & Fayed, O. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-1998-x · Cited by 2
Coleman, W. B., & Rubinas, T. C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374419-7.00004-4 · Cited by 2
Majumdar, S., Singh, P., Iyer, A., & Saravanan, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-444-63667-6.00001-8 · Cited by 2
Alokail, M. S., & Alenad, A. M. H. (2015) · InTech eBooks · doi:10.5772/59467 · Cited by 1
Heidari, Z., Asemi‐Rad, A., Moudi, B., & Mahmoudzadeh‐Sagheb, H. (2022) · Journal of International Medical Research · doi:10.1177/03000605221105344 · Cited by 2
“Transcriptional inactivation from promoter hypermethylation can affect genes involved in major cellular cancer-related pathways, including DNA repair, vitamin response, signaling, cell cycle control, and apoptosis pathways.(31) Hypermethylated promoters can be considered as new biomarkers in cancer diagnosis and progn…”
BackgroundThe Emerging Role of Epigenetics
Wang, L. Q., Singh, K. N., Zaw, A. M., & Chow, B. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1429-2_3 · Cited by 2
Basics of epigenetics: It is more than simple changes in sequence that govern gene expression
Sharma, S., & Aazmi, O. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814259-2.00001-7 · Cited by 2
Jaganathan, S. S., Natarajan, U., & Rathinavelu, A. (2025) · Epigenomics · doi:10.1080/17501911.2025.2558497 · Cited by 1
Moderne molekulare Onkodiagnostik aus methodischer Sicht
Bühler, H., & Adamietz, I. U. A. (2009) · Der Onkologe · doi:10.1007/s00761-009-1744-7 · Cited by 1
Génotoxicité et exposition professionnelle ou environnementale
Kirsch‐Volders, M., Decordier, I., & Lison, D. (2013) · EMC - Pathologie professionnelle et de l environnement · doi:10.1016/s1877-7856(12)58381-9 · Cited by 1
Soledad Reyes, J., Priscilla Brebi, M., Ili, C., Sergio Muñoz, N., Angélica Melo, A., & Rafael Guerrero, P. (2011) · International Journal of Morphology · doi:10.4067/s0717-95022011000100026 · Cited by 1
Powerline bioactivity - more than magnetism
Sidaway, G. H. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-454 · Cited by 1
“In this context note that Esteller (2007) proposed that hypermethylation of tumour suppressor genes may be related to the level of exposure to external carcinogen agents. Biologically important reactions of the superoxide radical are discussed by Maynard et al. (2009) who note that DNA bases, particularly guanine, are…”
BackgroundInfluentialDNA Methylation and Osteoarthritis
Roach, H. I. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_20 · Cited by 1
Epigenetic modification and cancer: mark or stamp?
Foulkes, W. D. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0003 · Cited by 1
“The ‘hypermethylome’ is emerging (Esteller 2007).”
Synthetic Genetic Approaches in Colorectal Cancer: Exploiting and Targeting Genome Instability
Sajesh, B. V., Cisyk, A. L., & McManus, K. J. (2014) · Cancer metastasis · doi:10.1007/978-3-319-12136-9_9 · Cited by 2
“Therefore, they can be maintained through cellular division and transmitted to all daughter progeny [68].”
BackgroundSciuscio, D., & Hegi, M. E. (2012) · Springer eBooks · doi:10.1007/978-0-85729-458-6_2 · Cited by 1
Epigenetic Changes and Potential Targets in Pancreatic Cancer
Singh, R., Lillard, J. W., & Singh, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-24951-3_2 · Cited by 1
Metadata
- Authors
- Esteller, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Corresponding author
- Esteller, Manel
- ORCID
- Esteller, Manel
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-04-15
- Volume
- 16
- Issue
- R1
- Pages
- R50-R59
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2158207797
- Cited by
- 725
- References
- 104
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 17 · 2023: 34 · 2022: 35 · 2021: 29 · 2020: 17 · 2019: 35 · 2018: 38 · 2017: 44 · 2016: 45 · 2015: 56 · 2014: 36 · 2013: 56 · 2012: 62
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Keywords
- epigenetic silencing, DNA hypermethylation, methylome, tumor suppressor, DNA methyltransferases, methyl-CpG binding domain proteins, histone deacetylase, histone methyltransferase, histone demethylase, Polycomb group proteins, DNA repair genes, microRNA, tumor markers, chemotherapy response prediction, epigenetic drugs, hematologic malignancies
- MeSH terms
- Werner Syndrome Helicase, Aging, Exodeoxyribonucleases, Humans, Neoplasms, RNA, Neoplasm, Werner Syndrome, Genes, Tumor Suppressor, CpG Islands, DNA Methylation, Gene Silencing, MicroRNAs, Epigenesis, Genetic, RecQ Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.